TEST AND PRICE LIST FOR NEXT GENERATION SEQUENCING



Similar documents
Next-generation sequencing can replace Sanger sequencing in clinical diagnostics.

La diagnostica molecolare nelle neoplasie colo-rettali. A do Scarpa. U iversita di Vero a

Nuovi Scenari in Oncologia. G. Zoppoli X-Files in Nutrizione Clinica e Artificiale, 08/06/2012

HEREDITARY CANCER GENE PANEL DG 2.3.x

CancerTREATMENT NGS+ NSCLC Summary Report Page 1 of 7 PATIENT SPECIMEN PHYSICIAN

Launching a Cancer Genetic Laboratory to Enhance Diagnosis and Treatment

Médecine de précision médecine personnalisée en Oncologie. Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN

1199 SEIU Benefit Funds Laboratory Management Program PRIOR AUTHORIZATION CODE LIST FOR OUTPATIENT MOLECULAR AND GENOMIC LABORATORY TESTS

Test Information Sheet

Hereditary Breast Cancer Panels. High Risk Hereditary Breast Cancer Panel Hereditary Breast/Ovarian/Endometrial Cancer Panel

Section: Genetic Testing Last Reviewed Date: October Policy No: 73 Effective Date: November 1, 2015

NEIGE. diagnosis In oncogenetics. Nicolas Sévenet 02 juillet

Oncomine Cancer Panel Patient Test Report

Beyond BRCA the Future is Now

Big Data Part I: Data-Driven Life Sciences Innovation, Personalized Medicine and Research

Test Information Sheet

A Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services. Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD

Ion AmpliSeq Technology

Ovarian Cancer Genetic Testing: Why, When, How?

Cancer Genomics & Precision Medicine in the 21 st Century. Lee J. Helman, MD Scientific Director for Clinical Research CCR, NCI

Opportunities and Challenges in Translating Novel Discoveries into Useful Clinical Tests

Microsatellite Instability (MSI) A New Paradigm in Cancer Treatment. Lynch Syndrome OUTLINE. GI Molecular Pathology

Approaches to Integrating Next Generation Sequencing into the Electronic Health Record

J Clin Oncol 32: by American Society of Clinical Oncology INTRODUCTION

High-Throughput Mutation Profiling Identifies Frequent Somatic Mutations in Advanced Gastric Adenocarcinoma

Hereditary Breast Cancer Testing. Diagnostic

Prevalenza delle mutazioni TMEM127 nel feocromocitoma sporadico

2014 CPT Code Updates

Genetics and Breast Cancer. Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service

The Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine

Target enrichment using selector probes. Department of Genetics and Pathology, Uppsala University

PATOLOGIA MOLECULAR DEL CANCER GINECOLOGICO. Xavier Matias-Guiu Hospital Universitari Arnau de Vilanova, Universitat de Lleida, IRBLLEIDA.

Breast and Ovarian Cancer

Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics

Molecular Human Genetics. Cancer, Tumor suppressor genes, Oncogenes

6/10/2015. Hereditary Predisposition for Breast Cancer: Looking at BRCA1/BRCA2 Testing & Beyond. Hereditary Cancers. BRCA1 and BRCA2 Review

How To Write A Cancer Sequencing

Genomic instability in cancers and cancer predispositions. Popova Tatiana Inserm U830 Institut Curie

Colon Cancer Syndromes. Robin B. Mendelsohn MD Memorial Sloan Kettering Cancer Center Department of Medicine Gastroenterology and Nutrition Service

Cardio Gene panel experience. Jan Jongbloed Laboratory Specialist Clinical Genetics Genome Diagnostics Department of Genetics UMCG Groningen

Common Cancers & Hereditary Syndromes

Submitted 12 September 2014; accepted 12 September 2014; advance online publication 13 November doi: /gim Genetics in medicine

Progress and Prospects in Ovarian Cancer Screening and Prevention

WHITE PAPER SEPT 2015

Molecular Pathology/Molecular Diagnostics/Genetic Testing

July 14, Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

Name of Policy: Genetic Testing for Inherited Cancer Predisposition and/or Pharmacogenetics related to Cancer Treatment

Next Generation Sequencing in Early-Phase Clinical Trials in Cancer Filip Janku

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes

Towards new classifications and individualised treatment for cancer patients

Metastatic Hereditary Breast Cancer: What s New? Melinda Telli, M.D. Assistant Professor of Medicine Stanford University School of Medicine

Clinical Use of Molecular in the Treatment of Lung Cancer

CANCER RESEARCH UK STRATIFIED MEDICINE PROGRAMME IAN WALKER PHD, MBA HEAD OF STRATIFIED MEDICINE

Molecular pathology of thyroid cancers

Disclosures. Personalized Meds from the molecular onco-pathology s perspective

Immunophenotyping of hereditary breast cancer

Application of Molecular Diagnosis: Present and Future

The Future of Clinical Chemistry and Laboratory Medicine, The Diagnostics Industry View

Name of Policy: Genetic Testing for Inherited Cancer Predisposition and/or Pharmacogenetics related to Cancer Treatment

UW Carbone Cancer Center Precision Medicine Molecular Tumor Board V Page 1

Stato dell arte e prospettive delle terapie a bersaglio molecolare nel carcinoma polmonare

Een behandeling op maat voor iedere patient: wat betekent dat in de praktijk? Emile Voest

Risk stratification for colorectal cancer especially: the difference between sporadic disease and polyposis syndromes. Dr. med. Henrik Csaba Horváth

Genomic Clinical Trials: NCI Initiatives

European Biotechnology. News. II Genomic Therapies and & Diagnostics SPECIAL. Science & Industry. April 2013

Stage III & IV colon and rectal cancers share a similar genetic profile: a review of the Oregon Colorectal Cancer Registry

Molecular Stratification of Cancer in the

Number Effective Date December 8, 2015 Revision Date(s) 12/08/15; 06/09/15; 02/10/15; 10/13/14; 05/12/14 Replaces 2.04.

National Medical Policy

Essais de médicine personnalisée en cancérologie. Jean-Charles SORIA

Pancreatic Cancer. Hereditary Pancreatic Cancer A Guide for Clinicians KNOWING WHAT TO LOOK FOR KNOWING WHERE TO LOOK AND KNOWING WHAT IT MEANS

Applications of comprehensive clinical genomic analysis in solid tumors: obstacles and opportunities

User Guide Thank you for purchasing the DX90

Riesgo genético y familiar. Javier Benitez Centro Nacional Investigaciones Oncológicas Madrid

Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing

The Fanconi anaemia/brca pathway and cancer susceptibility. Searching for new therapeutic targets

Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers

Recommendations for the management of early breast cancer

Molecular Diagnosis of Gastrointestinal Tumors

Genomic Medicine Education Initiatives of the College of American Pathologists

MRC-Holland MLPA. Related SALSA MLPA probemixes P417 BAP1: Contains probes for each exon of BAP1 gene on 3p21.

Oncogeni: fattori di crescita

Oncology Insights Enabled by Knowledge Base-Guided Panel Design and the Seamless Workflow of the GeneReader NGS System

***Next Generation sequencing testing options available effective April 18 th, 2016***

***Next Generation sequencing testing options available effective April 18 th, 2016***

Genomic Analysis of Mature B-cell Malignancies

Can molecular targeted therapies win the war against cancer?

THE LEADING EDGE FALL 2015 ISSUE. Welcome ICD-10 is Here for Pathology CLFS for Drugs of Abuse Testing... 5

GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED

MEDICAL POLICY Genetic Testing

Genetic Testing for Familial Adenomatous Polyposis and MYH-Associated Polyposis (Lynch Syndrome)

Molecular Diagnosis of Follicular Cell Nodules

2 nd PROCART Forum. October 9th, 2012

PATH-SCAN: A REPORTING TOOL FOR IDENTIFYING CLINICALLY ACTIONABLE VARIANTS

targeted cancer therapy

Population-based family studies: Genetic contribution to cancer development and survival?

Laboratory User Guides

Successes and Limitations of Targeted Cancer Therapy in Lung Cancer

1. Le mutazioni di KRAS hanno tutte lo stesso significato clinico?

Transcription:

AIP ALK APC Mutation Detection Techniques Ai Saple Type TAT ATM BAP1 BLM BMPR1A BRCA1 BRCA2 BRIP1 BUB1B CDC73 CDH1 CDK4 CDKN1C CDKN2A CEBPA CEP57 CHEK2 CYLD DDB2 DICER1 DIS3L2 EGFR EPCAM ERCC2 ERCC3 ERCC4 ERCC5 EXT1 EXT2 TEST AND PRICE LIST FOR NEXT GENERATION SEQUENCING Price ( Euro) Producer

EZH2 FANCA FANCB FANCC FANCD2 FANCE FANCF FANCG FANCI FANCL FANCM FH FLCN GATA2 GPC3 HNF1A HRAS KIT MAX MEN1 MET MLH1 MSH2 MSH6 MUTYH NBN NF1 NF2 NSD1 PALB2 PHOX2B PMS1 PMS2 PRF1 PRKAR1A

PTCH1 PTEN RAD51C RAD51D RB1 RECQL4 RET RHBDF2 RUNX1 SBDS SDHAF2 SDHB SDHC SDHD SLX4 SMAD4 SMARCB1 STK11 SUFU TMEM127 TP53 TSC1 TSC2 VHL WRN WT1 XPA XPC Lung Panel EGFR, KRAS, EML4ALK,AKT1, MET, ALK, NRAS BRAF, PIK3CA, CTNNB1 PTEN, MAP2K1, P53

Colon Panel KRAS, BRAF, AKT1, NRAS, APC, PIK3CA CTNNB1, PTEN, EGFR SRC, FBXW7, P53, MET Melanoa Panel BRAF, KIT, BRAF, MAP2K1, GNA11 NRAS, GNAQ, PIK3CA KIT, PTEN, KRAS Gastric Panel (GIST) KIT, PDGFRA,AKT1, PIK3CA FGFR2, P53 Ovarian Panel AKT1, PTEN ERBB2, P53 BRCA MASTR Dx HNPCC MASTR FAP MASTR CFTR MASTR v2 CFTR MAQ CFTR HP MARFAN MASTR FMF MASTR v2 DMD MASTR MODY MASTR ADH MASTR HCM MASTR HNF4A GCK HNF4A HNF1A HNF4A PDK1 HNF4A 15 days 1200 31 days 1200 32 days 1200 Tugen Tugen Tugen Tugen

HNF1B HNF4A FMF Gene Mutations Tugen Tugen